A combination of tigecycline, colistin, and meropenem against multidrug-resistant Acinetobacter baumannii bacteremia in a renal transplant recipient: pharmacodynamic and microbiological aspects.
about
Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment OptionsActivities of colistin- and minocycline-based combinations against extensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients.Identification of diverse OXA-40 group carbapenemases, including a novel variant, OXA-160, from Acinetobacter baumannii in PennsylvaniaFirst identification of OXA-72 carbapenemase from Acinetobacter pittii in Colombia.Dissemination of 16S rRNA methylase ArmA-producing acinetobacter baumannii and emergence of OXA-72 carbapenemase coproducers in Japan.High prevalence of carbapenem-resistant Acinetobacter baumannii carrying the blaOXA-143 gene in Brazilian hospitals.
P2860
A combination of tigecycline, colistin, and meropenem against multidrug-resistant Acinetobacter baumannii bacteremia in a renal transplant recipient: pharmacodynamic and microbiological aspects.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
A combination of tigecycline, ...... c and microbiological aspects.
@en
A combination of tigecycline, ...... c and microbiological aspects.
@nl
type
label
A combination of tigecycline, ...... c and microbiological aspects.
@en
A combination of tigecycline, ...... c and microbiological aspects.
@nl
prefLabel
A combination of tigecycline, ...... c and microbiological aspects.
@en
A combination of tigecycline, ...... c and microbiological aspects.
@nl
P2093
P1476
A combination of tigecycline, ...... ic and microbiological aspects
@en
P2093
Barrientos A
Culebras E
Matesanz M
P304
P577
2010-06-01T00:00:00Z